1. A Randomized Trial of Daclatasvir with Peginterferon Alfa-2B and Ribavirin for HCV Genotype 1 Infection. Issue 5 (July 2014) Authors: Suzuki, Fumitaka; Toyota, Joji; Ikeda, Kenji; Chayama, Kazuaki; Mochida, Satoshi; Hayashi, Norio; Ishikawa, Hiroki; Miyagoshi, Hidetaka; Hu, Wenhua; McPhee, Fiona; Hughes, Eric A; Kumada, Hiromitsu Journal: Antiviral therapy Issue: Volume 19:Issue 5(2014) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Issue 6 (1st April 2014) Authors: Kumada, Hiromitsu; Suzuki, Yoshiyuki; Ikeda, Kenji; Toyota, Joji; Karino, Yoshiyasu; Chayama, Kazuaki; Kawakami, Yoshiiku; Ido, Akio; Yamamoto, Kazuhide; Takaguchi, Koichi; Izumi, Namiki; Koike, Kazuhiko; Takehara, Tetsuo; Kawada, Norifumi; Sata, Michio; Miyagoshi, Hidetaka; Eley, Timothy; McPhee... Journal: Hepatology Issue: Volume 59:Issue 6(2014:Jun.) Page Start: 2083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study. Issue 3 (March 2023) Authors: Terasaka, Naoki; Spanopoulos, Dionysis; Miyagoshi, Hidetaka; Kubo, Toru; Kitaoka, Hiroaki Journal: Journal of cardiology Issue: Volume 81:Issue 3(2023) Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗